179 related articles for article (PubMed ID: 25924690)
1. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.
Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H
Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690
[TBL] [Abstract][Full Text] [Related]
2. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
3. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
4. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
5. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
[TBL] [Abstract][Full Text] [Related]
8. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
Chang A; Sandweiss L; Bose S
Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
[TBL] [Abstract][Full Text] [Related]
9. Significance of endometrial cells in cervical cytology.
Yu EJ; Park NH; Song YS; Lee YK
J Obstet Gynaecol; 2016 Oct; 36(7):966-969. PubMed ID: 27560859
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of benign endometrial cells in postmenopausal women.
Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system.
Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE
Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738
[TBL] [Abstract][Full Text] [Related]
12. Reporting of Benign Endometrial Cells in Papanicolaou Tests.
Hernandez A; Schatz-Siemers N; Zhou F; Brandler TC; Negron R; Modi L; Elgert PA; Simsir A
Am J Clin Pathol; 2020 Aug; 154(3):381-386. PubMed ID: 32405650
[TBL] [Abstract][Full Text] [Related]
13. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
14. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
Gomez-Fernandez CR; Ganjei-Azar P; Behshid K; Averette HE; Nadji M
Obstet Gynecol; 2000 Dec; 96(6):874-8. PubMed ID: 11084170
[TBL] [Abstract][Full Text] [Related]
15. Does Cytological Laboratory Holds the Responsibility for the Low Sensitivity of the PAP Test in Detecting Endometrial Cancer?
Milicić V; Matić TS; Martinek V; Tomasković I; Ramljak V
Coll Antropol; 2015 Sep; 39(3):713-7. PubMed ID: 26898071
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cells on Pap tests: ideal reporting is more complex than just finding the right age.
Fischer G; Haddad M; Cormier K
Diagn Cytopathol; 2017 Jul; 45(7):587-591. PubMed ID: 28421714
[TBL] [Abstract][Full Text] [Related]
17. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital.
Hinson S; Molberg K; Mir M; Flores M; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(2):78-83. PubMed ID: 31287423
[TBL] [Abstract][Full Text] [Related]
18. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Age Cutoff Criterion for Reporting Benign-Appearing Endometrial Cells in Routine Pap Tests: An 8-Year Retrospective Review.
Grada Z; Paquette C; Eklund CM; Zhang C; Sung CJ; Steinhoff M; Quddus MR
Acta Cytol; 2017; 61(3):194-198. PubMed ID: 28486237
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance and management approach of endometrial cells detected by cervical Pap cytology].
Li ZB; Xie ZX; Zhang HP; Zhao CQ
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):708-11. PubMed ID: 24433741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
